Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s
Pfizer's Bold Gambit: Unleashing New Weapons in the Global Battle Against Obesity
Metsera: The New Power Player Set to Disrupt the $100 Billion GLP-1 Market